Current Studies

Current Studies Available

Prostate Cancer: This is an observational Cohort Study of patients with Castration Resistant Prostate Cancer (CRPC).

The purpose of this prospective, observation study is to improve scientific understand of Prostate Cancer patient with castration resistant disease and the treatment patterns, quality of life and health care resources and cost associated with its management.

No mandated visits or procedures except a completion of Quality of Life Questionnaires every 3 months for the 1st year and at 3 months or 6 moths intervals thereafter.

Additional compensation for travel and other expenses will be provided.

Prostate Cancer: If you have Metastatic Hormone Sensitive Prostate Cancer (mHSPC) you may want to consider participating in ARCHES, a clinical research study.

The purpose of ARCHES is to see whether adding a daily oral investigational medication called enzalutamide to androgen deprivation therapy is safe and effective help slow prostate cancer disease progression. Androgen deprivation therapy is the standard treatment used to slow the growth and spread of prostate cancer.

Men, you may be able to join ARCHES if you:

  • Have been diagnosed with mHSPC
  • Have not received more than 6 cycles of treatment with docetaxel
  • Meet other criteria, which the study staff will discuss with you.

Clinical Trials In The Pipeline:

Looking for subjects that have been DX with Renal Cell Carcinoma, and Transitional Cell Bladder Cancer. This is a one-time blood draw which may aid in the development and improvement of new diagnostic test kits, devices, biomarker discovery and clinical medical research on particular disease and illness. Information about you is confidential, and you will compensated for your time.

Please contact Diane Gerrity if you are interested in finding out more information about clinical trials at:

(516) 742-3200 Ext. 302 or email us at: